MHRA approves Loba Biotech to manufacture Pegasys API, enabling pharma& to strengthen UK supply and ensure continued access for eligible patients. Following the MHRA decision, pharma& expects that ...

Would the cost-cutting measures for U.S. prescription drugs proposed by the Trump administration on Monday hurt the biotech sector more than pharma? We asked Seeking Alpha analysts Stephen Ayers ...

East Midlands-based biotechnology company N4 Pharma has formed a new senior leadership team featuring consultants in drug development and research, commercial strategy, and pharmaceutical ...

January kicked off the year with a flurry of notable leadership transitions across the pharmaceutical and biotechnology sectors. Here is a detailed look at the latest hires and departures.

February is the shortest month, but there was still plenty of time for a rush of pharma and biotech hires, including a number of changes at the big pharmas, which may have slipped under your radar ...

Ailsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek where they’d ...

After years of stagnation, Gilead is betting that a twice-yearly HIV shot can restart its growth engine.

Die große Frage: Kann Heidelberg Pharma den positiven Trend fortsetzen? Viel hängt davon ab, wann erste Zwischendaten aus der HDP-102-Studie veröffentlicht werden. Bis dahin dürfte der Titel ...

By Michael Levenson 23andMe, the genetic testing company that was once valued at $6 billion but filed for bankruptcy in March, will be bought by Regeneron Pharmaceuticals, a biotechnology company ...

Biontech wurde mit dem Deutschen Nationalpreis 2025 ausgezeichnet und zeigt durch Kooperationen und Übernahmen, wie ...

There's no reason the U.S. can't pick up the pace to match the global clinical research front-runners without compromising ...